Abstract

IntroductionOptic neuritis, although uncommon, can be the initial presentation of Sjögren’s syndrome. Coexisting Sjögren’s syndrome has also been reported with neuromyelitis optica spectrum disorder. This case report highlights the association between the two diseases and the importance of rheumatological and neurological evaluations in patients with such diagnoses. Distinction of neuromyelitis optica with coexisting connective tissue disease has both prognostic and therapeutic significance for the patient.Case presentationWe report a case of a 56-year-old Chinese woman who presented with bilateral asymmetric visual loss secondary to optic neuritis. She was subsequently found to be seropositive for neuromyelitis optica immunoglobulin G (NMO-IgG) (anti-aquaporin-4 antibody) and was diagnosed with neuromyelitis optica spectrum disorder. She also fulfilled the international criteria for Sjögren’s syndrome. Despite initial high dose immunosuppressive therapy, she failed to regain vision in one eye.ConclusionPatients presenting with optic neuritis and severe visual loss should be screened for neuromyelitis optica and treated appropriately. Neuromyelitis optica has been associated with systemic autoimmune diseases, in particular Sjögren’s syndrome, and current evidence indicates that they are two distinct entities. We recommend that both diagnoses be considered in cases of optic neuritis with severe visual loss.

Highlights

  • Optic neuritis, uncommon, can be the initial presentation of Sjögren’s syndrome

  • Case presentation: We report a case of a 56-year-old Chinese woman who presented with bilateral asymmetric visual loss secondary to optic neuritis

  • Patients presenting with optic neuritis and severe visual loss should be screened for neuromyelitis optica and treated appropriately

Read more

Summary

Conclusion

Current literature suggests NMO as a distinct entity from MS requiring different treatment modalities; as such, patients presenting with ON and severe visual loss should be screened for NMO and treated appropriately. NMO has been associated with systemic autoimmune diseases, in particular SS, and current evidence indicates that they are two distinct entities. Authors’ contributions PT was involved in the care of the patient, and was a major contributor in writing the manuscript and literature review. TU was involved in the care of the patient and editing the manuscript. SAL was involved in the care of the patient and editing of the manuscript. Author details 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. 2Department of Neuroradiology, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. 3Department of Neurology, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore

Introduction
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call